Safety and Efficacy of Apremilast Through 104 Weeks in Patients Swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study. J of Skin 2017, 1 (3.1), s32. https://doi.org/10.25251/skin.1.supp.31.